Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
New

A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors

for
Locally Advanced /Metastatic Solid Tumors,
Location: Houston TX
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07940881

Phase 1, Recruiting
New

Medically Tailored Meals to Improve Cancer Outcomes

for
Cancer, Healthy Eating
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07924241

Recruiting
New

Pilot Study of Hydroxychloroquine for the Treatment of AIMSS

for
Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS),
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT07825454

Phase 2, Recruiting
New

Improving Care Delivery for Patients With Mental Illness and Cancer Across a Cancer Center Network

for
Cancer, Serious Mental Illness
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07707362

Recruiting
New

A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

for
Breast Cancer, Hormone-receptor-positive Breast Cancer,
Location: Fairfax VA, Tamarac FL, Maumee OH
Sponsor: Prelude Therapeutics Incorporated

Sex: All

Age: 18+

Code: NCT07905001

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy

for
Breast Cancer, Breast Cancer Female
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT07918989

Phase 2, Recruiting
New

Personalize My Treatment (PMT) Registry

for
Cancer
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Sex: All

Age: 18+

Code: NCT02355171

Recruiting
New

A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)

for
Malignant Neoplam, Advanced Solid Tumors
Location: Belleville NJ, East Brunswick NJ, Toronto, Maumee OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07793942

Phase 2, Recruiting
New

SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

for
Locally Advanced /Metastatic Solid Tumors,
Location: Orlando FL, Sarasota FL, Nashville TN, Dallas TX
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07857616

Phase 1, Recruiting
New

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07542704

Phase 1, Recruiting
New

A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment

for
Early Breast Cancer, Estrogen Receptor-Positive Breast Cancer,
Location: Quebec, Montreal, Richmond VA, Salem OR
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07827573

Phase 3, Recruiting
New

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

for
Adenocarcinoma, Prostate Cancer, Neoplasms, Carcinoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18 - 70+

Code: NCT07574541

Phase 2, Recruiting
New

A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer

for
Breast Cancer, Invasive Breast Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07899892

Phase 1, Recruiting
New

A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer

for
Advanced Solid Tumour
Location: Sarasota FL, Nashville TN
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07851103

Phase 1, Recruiting
New

A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment

for
Dysgeusia, Solid Tumor
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07419581

Recruiting
New

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

for
Prostate Cancer, Breast Cancer, Neuroendocrine Tumors
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT05160480

Recruiting
New

Short-Term Reduced Dietary Protein in ER+/HER2- Breast Cancer Patients During Neoadjuvant Chemotherapy

for
Breast Cancer,
Location: Stony Brook NY
Sponsor: Josephine Connolly-Schoonen

Sex: Female

Age: 18 - 70+

Code: NCT07897344

Recruiting
New

Facial Expression Awareness Training to Understand and Recognize Emotions

for
Survivors of Pediatric Brain Tumors, Pediatric Cancer
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 6 - 13

Code: NCT07923370

Recruiting
New

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07737314

Recruiting
New

Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC

for
Triple-Negative Breast Cancer (TNBC)
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07698106

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial